OCT4, NANOG, and c-MYC overexpression has been implicated in metastasis in many cancer types, including MM, in which cells expressing these markers have been shown to confer aggressive motility phenotypes, thus promoting invasiveness [21,22,23]. The gene discussed is MYC; the disease is Miyoshi myopathy.